Form 4 holding
Director
Travere Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 39,375
- Estimated value
- $1,169,831
- Report date
- 19 May 2026
- Price
- $29.71
- Ownership
- Direct
John A. Orwin - Director at Travere Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TVTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by John A. Orwin since 08 Aug 2025
Reported holdings for John A. Orwin in Travere Therapeutics, Inc.
Form 4 holding
Director
Travere Therapeutics, Inc.
- Security class
- Stock option (right to buy)
- Shares / value
- 12,000
- Estimated value
- Report date
- 19 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John A. Orwin in Travere Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.